Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 487 across all filing types
Latest filing 2026-06-05 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, JUNE 30, 2026
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for the Annual General Meeting of Transcenta Holding Limited, providing shareholders with voting instructions and proxy appointment for resolutions at the AGM. It is not the minutes or results of the meeting but solicits shareholder votes. This falls squarely under 'Proxy Solicitation & Information Statement' (PSI).
2026-06-05 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of the company’s upcoming Annual General Meeting, outlining resolutions to be voted on, proxy appointment procedures, and meeting details. This notice is sent to shareholders to provide information and solicit votes. It is not the Annual Report itself, not dividend or share transaction notices, and not an earnings release. It falls under Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to inform them about a meeting and request their vote.
2026-06-05 English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND PROPOSED RE-APPOINTMENT OF AUDITOR AND
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a comprehensive circular sent to shareholders of Transcenta Holding Limited ahead of its Annual General Meeting, containing detailed information on resolutions (re-election/appointment of directors, grant of mandates, auditor re-appointment), proxy arrangements, and the formal notice of meeting. It is not itself a full annual or interim report but a solicitation of proxies and information statement for voting purposes. According to the filing definitions, this matches a Proxy Solicitation & Information Statement.
2026-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Share Issue/Capital Change Classification · 85% confidence The document is the Hong Kong Exchange (HKEX) Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts…on Movements in Securities,” which reports changes in authorised/issued share capital, treasury shares and share option schemes for the month ended 31 May 2026. It is a routine regulatory submission detailing capital movements rather than an annual or interim financial report. This clearly falls under announcements of share capital changes. Therefore, it should be classified as Share Issue/Capital Change (SHA).
2026-06-04 English
CHANGE OF DIRECTORS AND CHANGE IN THE COMPOSITION OF BOARD COMMITTEES
Board/Management Information Classification · 95% confidence The document is an official announcement regarding the proposed appointment and resignation of directors and changes in the composition of board committees for Transcenta Holding Limited. It details biographical information of incoming non-executive and independent non-executive directors, terms of appointment, resignations of existing directors, and committee reassignments. This fits squarely into the “Announcement of changes in the company's board of directors or senior management” category.
2026-06-04 English
VOLUNTARY ANNOUNCEMENT-TRANSCENTA REPORTS RECEIPT OF HICB OUT-LICENSING MILESTONE PAYMENT AND STEADY CDMO BUSINESS GROWTH
Regulatory Filings Classification · 82% confidence The document is a voluntary business update announcement by a Hong Kong listed company describing receipt of a milestone payment and CDMO business growth. It contains no actual financial statements or formal meeting materials, nor is it announcing share issues, dividends, or management director appointments as the primary focus. It is not an earnings release or regulatory certification but a general corporate update provided to investors. This fits the fallback category for miscellaneous regulatory announcements (RNS).
2026-05-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.